tiprankstipranks
Aclaris Therapeutics (DE:8AT)
FRANKFURT:8AT
Holding DE:8AT?
Track your performance easily

Aclaris Therapeutics (8AT) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Aclaris Therapeutics’s (8AT) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Aclaris Therapeutics is a Buy.
Aclaris Therapeutics’s (8AT) 20-Day exponential moving average is 3.15, while Aclaris Therapeutics’s (8AT) share price is €2.642, making it a Sell.
Aclaris Therapeutics’s (8AT) 50-Day exponential moving average is 2.70, while Aclaris Therapeutics’s (8AT) share price is €2.642, making it a Sell.

Aclaris Therapeutics (8AT) Pivot Points

Dec 22, 2024, 07:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.94
2.94
2.94
2.94
2.94
2.94
2.94
Fibonacci
2.94
2.94
2.94
2.94
2.94
2.94
2.94
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aclaris Therapeutics (8AT) Moving Averages

Dec 22, 2024, 07:30 AM
Period
Simple
Exponential
MA5
2.89Sell
2.91Sell
MA10
3.16Sell
3.08Sell
MA20
3.41Sell
3.15Sell
MA50
2.55Buy
2.70Sell
MA100
1.80Buy
2.15Buy
MA200
1.44Buy
1.70Buy
Aclaris Therapeutics’s (8AT) 10-Day exponential moving average is 3.08, while Aclaris Therapeutics’s (8AT) share price is €2.642, making it a Sell.
Aclaris Therapeutics’s (8AT) 100-Day exponential moving average is 2.15, while Aclaris Therapeutics’s (8AT) share price is €2.642, making it a Buy.
Aclaris Therapeutics’s (8AT) stock price is €2.642 and Aclaris Therapeutics’s (8AT) 50-day simple moving average is 2.55, creating a Buy signal.
Aclaris Therapeutics’s (8AT) stock price is €2.642 and Aclaris Therapeutics’s (8AT) 100-day simple moving average is 1.80, creating a Buy signal.
Aclaris Therapeutics’s (8AT) stock price is €2.642 and Aclaris Therapeutics’s (8AT) 200-day simple moving average is 1.44, creating a Buy signal.

Aclaris Therapeutics (8AT) Technical Indicators

Dec 22, 2024, 07:30 AM
Name
Value
Implied Action
RSI (14)
41.53
Neutral
STOCH (9,6)
13.02
Buy
STOCHRSI (14)
10.83
Buy
MACD (12,26)
0.04
Buy
ADX (14)
28.97
Neutral
Williams %R
-100.00
Buy
CCI (14)
-170.27
Buy
ATR (14)
0.20
-
Ultimate Oscillator
27.24
Sell
ROC
-30.35
Sell
Aclaris Therapeutics’s (8AT) Relative Strength Index (RSI) is 41.53, creating a Neutral signal.
Aclaris Therapeutics’s (8AT) Trend Strength Indicator (ADX) is 28.97, creating a Neutral signal.
Aclaris Therapeutics’s (8AT) Commodity Channel Index (CCI) is -170.27, creating a Buy signal.
Aclaris Therapeutics’s (8AT) Price Rate of Change (ROC) is -30.35, creating a Sell signal.

FAQ

Is 8AT a Buy, Hold, or Sell?
Based on 8AT’s technical indicators, 8AT is a Hold.
    What is 8AT’s RSI (14)?
    8AT’s RSI (14) is 41.53, which suggests 8AT is a Neutral.
      What is 8AT’s MACD?
      8AT’s MACD is 0.04, which suggests 8AT is a Buy.
        What is 8AT’s 5-day moving average?
        8AT’s 5-day moving average is 2.89, which suggests 8AT is a Sell.
          What is 8AT’s 20-day moving average?
          8AT 20-day moving average is 3.41, which suggests 8AT is a Sell.
            What is 8AT’s 50-day moving average?
            8AT’s 50-day moving average is 2.55, which suggests 8AT is a Buy.
              What is 8AT’s 200-day moving average?
              8AT’s 200-day moving average is 1.44, which suggests 8AT is a Buy.
                What is 8AT’s Williams % R (14)?
                8AT’s Williams % R (14) is -100.00, which suggests 8AT is a Buy.
                  What is 8AT’s CCI (14)?
                  8AT’s CCI (14) is -170.27, which suggests 8AT is a Buy.
                    What is the share price of Aclaris Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis